Related Experiment Video
Updated: Sep 10, 2025
02:47
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
1.5K
Cardiovascular and Metabolic Disease: New Treatment and Future Directions-The 3rd Edition
1Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, 00166 Rome, Italy.
Biomedicines
|August 28, 2025
Insights
Cardiovascular and metabolic diseases are major global health challenges. Addressing these complex conditions is crucial for improving public health outcomes and reducing healthcare burdens.
Area of Science:
- Cardiology
- Metabolic Medicine
- Public Health
Background:
- Cardiovascular and metabolic diseases represent significant global health burdens.
- These conditions profoundly affect individual well-being and strain healthcare systems worldwide.
- Urgent research and intervention strategies are needed to mitigate their impact.
Discussion:
- The interconnectedness of cardiovascular and metabolic systems necessitates a holistic approach to disease management.
- Understanding the multifactorial etiology of these diseases is key to developing effective prevention and treatment plans.
- Innovative therapeutic strategies and lifestyle interventions are critical for combating the rising prevalence of these conditions.
Key Insights:
- Highlighting the critical need for research into cardiovascular and metabolic diseases.
- Emphasizing the substantial impact on individuals and healthcare infrastructures.
- Underscoring the urgency for comprehensive health strategies.
Outlook:
- Future research should focus on personalized medicine and preventative care for cardiovascular and metabolic disorders.
- Interdisciplinary collaboration is essential for advancing treatment modalities and public health policies.
- A concerted global effort is required to reduce the morbidity and mortality associated with these prevalent diseases.
Abstract:
Cardiovascular and metabolic diseases remain the most pressing global health concerns of our time, with a profound impact on both individual lives and healthcare systems [...].
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
01:15Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21